Back to Search
CHONG SHOU, MD
MD
Hospitalist Physician
NPI: 1508125535IndividualAccepts Medicare
Education
OTHER
Class of 2010
Research & Publications (20)
Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
PMID 19236507·Histopathology·2009
8-other
Zebrafish miR-1 and miR-133 shape muscle gene expression and regulate sarcomeric actin organization.
PMID 19240126·Genes Dev·2009
7-preclinical
Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.
PMID 19247814·Pathol Oncol Res·2009
8-other
Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.
PMID 19322925·World J Gastroenterol·2009
8-other
The transcriptional landscape of the yeast genome defined by RNA sequencing.
PMID 18451266·Science·2008
8-other
Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer.
PMID 18325661·Cancer Lett·2008
7-preclinical
Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
PMID 18586385·Cancer Lett·2008
8-other
p37 from Mycoplasma hyorhinis promotes cancer cell invasiveness and metastasis through activation of MMP-2 and followed by phosphorylation of EGFR.
PMID 18347140·Mol Cancer Ther·2008
8-other
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
PMID 17534899·Int J Cancer·2007
7-preclinical
[Phosphatase of regenerating liver-3 (PRL-3) and tumor metastasis].
PMID 17575683·Zhonghua Zhong Liu Za Zhi·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 585 LEBANON ST
MELROSE, MA 02176 - Phone
- (781) 979-3861
Quick Facts
- NPI
- 1508125535
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile